跳至主要内容
临床试验/KCT0002277
KCT0002277已完成未知

A randomized and prospective study about effects and safety of prophylactic dexamethasone on post transarterial chemoembolization syndrome

The Catholic University of Korea, Seoul St. Mary's Hospital0 个研究点目标入组 88 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
88

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
18(Year) 至 80(Year)(—)
性别
All

入选标准

  • (1) age 18-80 years,
  • (2) an Eastern Cooperative Oncology Group performance status of zero,
  • (3) Child-Pugh Class A,
  • (4) intermediate stage HCC (BCLC B) according to the BCLC staging classification,
  • (5) treated with TACE with doxorubicin,
  • (6) a serum creatinine level lower than 1.5 mg/dL.

排除标准

  • (1) concurrent serious medical condition(s) such as underlying cardiac or renal disease,
  • (2) other concurrent primary malignancy,
  • (3) other chemotherapy, such as hepatic arterial infusion chemotherapy or systemic chemotherapy,
  • (4) chronic hepatitis B patients who were not treated with antiviral therapy because steroids can induce viral reactivation in patients with chronic hepatitis B and who were not treated with antiviral therapy.

研究者

相似试验